Sarcoidosis does not automatically indicate an immunocompromised diagnosis. FSR cannot determine or provide recommendations for your individual immunocompromised status. Please consult your physician for personalized medical advice.

On Friday, August 13, 2021, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization for the Pfizer-BioNTech and Moderna vaccines to allow an additional dose (booster) for certain immunocompromised individuals. The Center for Disease Control (CDC) also issued guidance on who qualifies for the booster. Below is summary of their guidance.

Who is eligible?

The CDC’s Advisory Committee on Immunization Practices (ACIP) define immunocompromised as including those who are:

    • Under treatment for cancer
    • Received a solid organ transplant
    • Received bone marrow or stem cell transplant in the last 2 years or is on immunosuppression due to stem cell transplant
    • Received CART-cell in the last 2 years (a specific type of cancer treatment)
    • Diagnosed with immunodeficiency syndrome (includes: Common Variable Immune Deficiency, DiGeorg Syndrome, Wiskott-Aldrich syndrome)
    • Have an advanced CD4 count (under 200) or untreated HIV infection
    • Have been actively treated within the last month with any of the following immunosuppressive drugs:
        • High dose corticosteroids (at least 20mg of more of prednisone for 14 days or longer)
        • Alkylating agents (such as: cyclophosphamide, temozolomide, chlorambucil, carboplatin, cisplatin)
        • Antimetabolites (such as: methotrexate, hydroxyurea, gemcitabine, fludarabine)
        • TNF alpha inhibitors (such as: adalimumab, etanercept, infliximab)
        • Other biologic agents which are substances that are made from a living organism or its product that modify the immune response or the functioning of the immune system (such as: rituximab, anakinra, golimumab, natalizumab, mycophenolate)

     

    Which vaccines are eligible for the booster?

    Patients have already received 2 doses of a mRNA COVID-19 vaccine (e.g., Pfizer or Moderna) with the 2nd dose at least 28 days ago.

    NOTE:*This booster does not include the Johnson & Johnson vaccine and does not apply to people who are not immunocompromised* If you have additional questions about whether you should be considered for a booster, please contact your physician for further clarification.

 

Read more COVID-19 updates from FSR.